Title:
Longevity & Vitality - A Renaissance of Drugs and Genomics
Blog owner post:
Peter Diamandis
Published:
tech blog, 21 June 2020
https://www.diamandis.com/blog/longevity-drugs-and-genomics
From the blog post:
The causes of aging are extremely complex and unclear.
But with longevity clinical trials increasing 3.5X, from 73 in 2012 to over 258 in 2019, more answers — and questions — are emerging than ever before.
With the dramatic demonetization of genome reading and editing over the past decade, and Big Pharma, startups, and the FDA starting to face aging as a disease, we are starting to turn those answers into practical ways to extend our healthspan.
In this blog, I will explore how genome sequencing and editing, along with new classes of anti-aging drugs, are augmenting our biology to further extend our healthy lives.